Zymeworks(ZYME) - 2024 Q1 - Quarterly Results

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results Vancouver, British Columbia (May 2, 2024) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today reported financial results for the three months ended March 31, 2024 and provided a summary of recent business highlights. "We are very pleased to have presented five pos ...